Breast Implants

Mark Durkan Excerpts

Wednesday 11th January 2012 Commons Chamber

[Mr Lansley]

I am sorry to disappoint my hon. Friend but I cannot offer him such an estimate. We know that some 37,000 women had PIP breast implants. Clearly, not all those will necessarily want removal, and on advice, it might be any proportion of those; I cannot tell him what that figure would be. As we see in France, recommending the removal of implants does not mean that all women will have them removed.

[Mark Durkan (Foyle) (SDLP)]

I acknowledge the Secretary of State’s commitment to engaging proactively with the devolved Administrations on this issue. However, in his statement he used somewhat clumsy language regarding the third main finding of the expert group, saying that “there is no clear evidence that these problems are more serious in relation to PIP implants than other implants, or that they result in increased long-term health risks.” Is he not concerned that, put so clumsily, that will not only fail to reassure those with PIP implants but extend concern and alarm to those who have received other implants?

[Mr Lansley]

I am afraid that absence of evidence does not mean evidence of absence. We can be very clear, on expert advice, that there are no specific safety concerns that routinely require the removal of these implants, nor identification of any increased long-term health risks, in precisely the way I have described. I cannot go further and provide, on advice, absolute assurance, and the expert group was clear about that. That is why the French Health Minister, whom I was talking to last week, and I were clear that we should undertake additional toxicology tests on implants when they are explanted, in cases where they were implanted over a period of time, to begin to understand the extent to which they had adulterated filler material and what was in it.

Southern Cross Care Homes

Mark Durkan Excerpts

Tuesday 12th July 2011 Commons Chamber

[Paul Burstow]

As I said to my hon. Friend the Member for St Ives (Andrew George), 77% of adult social care is already in the private sector, and as we said in “A vision for adult social care”, we want a more vibrant, diverse market which includes voluntary sector providers. We want to examine the role of regulation, to ensure that it assists with the management of that market and, fundamentally, to ensure that it protects the rights and best interests of those who use these services.

[Mark Durkan (Foyle) (SDLP)]

Will the Minister assure me that consultation with the devolved authorities will take account of the different mix of landlords and lenders there? On a wider issue, will he assure the House that the undertakings he has given in respect of older residents will apply, at least equally, to much younger residents who are receiving bespoke care packages for conditions such as acquired brain injuries, often on a different contractual basis and outside the normal Southern Cross business model? Will such people be fully taken care of?

[Paul Burstow]

I am grateful to the hon. Gentleman for his question, which allows me to deal with an earlier question on the same subject. The answer is absolutely yes. The continuity of care will be not just for the benefit of older residents of care homes, but for the benefit of any individual who relies on the services provided by the company.

Winterbourne View Care Home

Mark Durkan Excerpts

Tuesday 7th June 2011 Commons Chamber

[Paul Burstow]

I am afraid that I am not going to agree with the hon. Gentleman today that we should call for anyone’s head. I want the heads of that organisation to be relentless in pursuing the questions that hon. Members have asked today and which I have asked since this came to light about why failures occurred—not just the CQC’s acknowledged failure but failures by others in allowing this to go on for the time it did. I am not calling for resignations, but I am calling for action and resolution. Learning should take place, and there should be change as a result of that learning.

[Mark Durkan (Foyle) (SDLP)]

The Minister has rightly addressed the issue of whistleblowers. Will he assure us that there will be protection for whistleblowers in future, whether they are relatives or staff, so that they have the confidence to act? In relation to staffing issues, are any of the inquiries making any assessment of whether there is a correlation between shift lengths and pay rates and the poor care in some of those institutions?

[Paul Burstow]

Again, those are all matters that need to be properly considered and weighed up in the reviews and that the Department will want to make sure is part of the overall report. When that work concludes, we will report to the House and make sure that the information is available to all hon. Members so that they can assess it and make their own judgments. It is certainly the Government’s intention to strengthen the protections on whistleblowing. We are consulting on how that might be given effect, and I urge the hon. Gentleman to contribute to the consultation.

Neuromuscular Care (North-West)

Mark Durkan Excerpts

Wednesday 9th February 2011 Westminster Hall

[Mark Durkan (Foyle) (SDLP)]

It is a pleasure to serve under your chairmanship, Mr Davies. I congratulate the hon. Member for Weaver Vale (Graham Evans) on securing this debate, which is important to many people. Although the title of the debate refers to neuromuscular services in the north-west, my constituency neighbour the hon. Member for East Londonderry (Mr Campbell) and I come from the north-west of a different island. This is not revenge for the map-reading errors that many of us would have heard excuses for over the years in border areas in Northern Ireland, nor is it an attempt to hijack this debate. I want to give positive support to the articulate efforts of the hon. Member for Weaver Vale, who spoke compellingly about what muscular dystrophy can mean for the individuals affected and their families.

Unlike the hon. Gentleman, I do not have a relative who suffers from muscular dystrophy, but I remember being particularly impressed by a young constituent of mine and his family. My constituent, who unfortunately died a couple of years ago, was named Donovan McKeever. When his parents, Brendan and Teresa, heard Donovan’s diagnosis, they were confounded by the degree to which nobody knew what to say to them or what they were talking about, asking about or looking for. Donovan’s father Brendan wrote a small book about his experience, titled “It Shouldn’t Have to Be Like This”.

Unfortunately, when a child is diagnosed with muscular dystrophy—this also happens with many other conditions, such as autism—parents often have to navigate systems and negotiate between services as though they were the first to find themselves in that situation. The hon. Gentleman’s speech reflected such frustrations. Because people know the good work of the Muscular Dystrophy Campaign and know that it is a recognised disease, they assume that care services are in place and that the system kicks in and knows what to do, how to pass people on and how to connect services. They assume that key workers exist to ensure that needs are met, whether that involves a disabled facilities grant for adapting housing, or assistance deciding which school environment will be most conducive or accessible. Families need support, and they expect the system to provide it. For people with muscular dystrophy—Donovan had Duchenne muscular dystrophy—that does not always happen.

The hon. Gentleman mentioned the importance of care advisers, as did the hon. Member for East Londonderry in his intervention. Northern Ireland has a muscular dystrophy care adviser, but unfortunately the funding for that care adviser is committed only until the end of March, and no long-term funding is in place. Not only are things not as they should be, but the existing service and the commitments that have been made may well disappear in the context of budget squeezes and other changes.

We should use this occasion to call for better services, planning and support, not just in the interest of individuals with such conditions and their families but in the interest of providing well-managed public services and savings. The hon. Member for Weaver Vale mentioned unplanned emergency admissions. Some 2,000 people in Northern Ireland suffer from muscular disease, and their unplanned emergency admissions cost at least £2.25 million a year. Better and more appropriate and available services would lead to savings. Making people present themselves in a less appropriate context puts pressure on other services and adds to costs, which is not efficient. Cutting corners in such areas in the name of efficiency savings is wrong, and some of the cuts and squeezes taking place are counter-efficient.

I know that the Minister is particularly concerned about the health services that the hon. Gentleman and I have mentioned. The issues on which patients need to engage the public policy system are not confined to clinical presentations. In the context of some other changes that the Government are introducing, such as changes to disability living allowance and medical assessments, I would hope that the Minister acts as an advocate for patients with muscular dystrophy to ensure that they are not overburdened by medical assessments. They find it difficult enough to navigate the system and get the services that they expect; it should not be made harder for them to get support such as disability living allowance and the mobility component.

On the intended removal of the mobility component of DLA from people in residential care, many young adults with muscular dystrophy choose to live in a residential care setting because of their situation. Their parents may have passed on, and other family members may have moved on. It is nonsense for people who have made that choice to lose the mobility component, with all the social support, access, personal outlets and socialising that it allows. I hope that this debate is not purely about the important issue of clinical and medical services for those with muscular dystrophy; I hope that we will take a holistic approach to people’s particular needs.

The hon. Member for Weaver Vale mentioned specialist multidisciplinary care. If we break the issue down to our different locations, whether we are talking about the new single commissioner for Northern Ireland, the Health and Social Care Board—

[Philip Davies (in the Chair)]

Order. I do not wish to interrupt the hon. Gentleman’s flow, but I hope that he appreciates that the terms of the debate relate specifically to the north-west. Although his comments on Northern Ireland are interesting, I hope that he will tie them in to the situation in the north-west, as that is the title of the debate.

[Mark Durkan]

I fully accept your admonition, Mr Davies. I made that point at the start.

If we consider specialist multidisciplinary care in relation only to different localities—whether primary care trusts and GP-led commissioning in the north-west of England or purely within the devolved regions of Scotland or Northern Ireland—we might miss a point. In the case of rarer diseases and conditions, a bigger commitment and wider consideration at a UK level provides a better context of scale. As we have heard, individual GPs sometimes are not good at responding to particular needs or realising the importance of a condition because they do not see enough instances of it. That problem applies not only to GPs but, more broadly, to other services and public management bodies.

I hope that, during the Minister’s tenure, the Joint Ministerial Committee, which brings together Ministers from the devolved entities as well as those from Whitehall, and the British-Irish Council will undertake initiatives to examine whether we can learn lessons from one another. When I was a Minister in the Northern Ireland Assembly, I was privileged to attend the council’s very first meeting. I remember the late Donald Dewar saying that one of the most undervalued art forms was plagiarism and that we needed a vehicle to bring together public policy planners and overseers, such as Ministers, from different parts of these islands. We need that not just in order to see who is doing well at what and to copy them, but in order to be honest and admit what we are all doing badly; to discuss the serious issues that we are not doing enough about; and to constantly agree, as public representatives, that more should be done and that there should be better laws, better services and better funding. If we cannot do enough of that in relation to our own individual pressures, perhaps the British-Irish Council and the Joint Ministerial Committee can together ask some of the fundamental questions, at the heart of government, that were raised by the hon. Member for Weaver Vale.

Contaminated Blood and Blood Products

Mark Durkan Excerpts

Thursday 14th October 2010 Commons Chamber

[Rehman Chishti]

The hon. Gentleman is absolutely right to say that there is the question of liability, and I understand that it was dealt with at the judicial review, when the High Court addressed it. In Ireland, the issue of fault was raised.

[Mark Durkan (Foyle) (SDLP)]

The previous Government retold the fiction several times that the compensation scheme in Ireland rested on the finding of liability, but that scheme existed in Ireland before the finding of liability, be it by either the Finlay or Lindsay tribunals.

[Rehman Chishti]

I am grateful to the hon. Gentleman for that. The point that I was making about the Government and clarification related to the judicial review, which examined that very matter.

The other point I wish to make has been touched on eloquently by other Members. Since 1989, this individual has not been able to go on holiday, because of problems with travel and life insurance. Those matters must be dealt with swiftly, given the length of time left for him to live, so that he can enjoy that time with his family. I welcome the fact that he can be here to sit in the Public Gallery in this House to hear this debate.

Finally, I urge the Minister to provide specific counselling for those people who have suffered from this tragedy. I thank you, Madam Deputy Speaker, for allowing me to speak and the Backbench Business Committee for bringing this motion to the Floor of the House.

--- Later in debate ---

[Mark Durkan (Foyle) (SDLP)]

Unlike some other hon. Members, I do not have permission to name any constituent who suffers from this predicament. However, I do hear from people who are affected, as well as from those in other constituencies in Northern Ireland, about exactly the same problems, tensions and sad experiences that other hon. Members have so articulately reflected on.

Many hon. Members in this debate have emphasised the importance of ensuring parity between sufferers from hepatitis C and sufferers from HIV, and the principle seems to be shared universally across the House. My problem, in a border constituency in Northern Ireland, is that I want to see parity between my constituents in Foyle and those in the next-door constituency of Donegal North East, who benefit from the Irish Government’s compensation scheme. That scheme had its roots in the recognition in 1995, by the then Irish Government—the rainbow coalition of John Bruton and Dick Spring—that led to a tribunal being set up in 1996, which was making significant payments long before the subsequent findings of liability by the Lindsay or Finlay tribunals, or by the hepatitis C tribunal in 2002.

Not only have we had the scandal of the health mistreatment disaster, which created this plight for so many people; there has also been the scandal of the failure of the political process to deal with it. There is no point in our talking about this or that Government; the fact is that, collectively, the political process has failed to discharge its responsibilities properly, as compared with what a nearby political process has been able to deliver. The word “scandal” is much overworked in this society, in the media and in politics, but what we are talking about is a true scandal, and we have to call a halt to it now.

In the past, we had Governments giving false excuses and making false comparisons with the Irish scheme, with false references to the issue of liability and so on. Now that has been nailed. However, after the false contrasts of the past, we cannot now have false comparisons to describe the relative or comparative costs of the schemes. Clearly we need proper differentiation between the wider package that was available in the south of Ireland, to take account of the fact that not everybody had health cover, prescription cover, medical card cover or whatever. I accept that that has to be done properly if we are to achieve true parity. However, we cannot turn round and offer the victims stone for bread, and say that now that we have finally recognised the problem and are addressing it, our excuse for not giving them what justice demands is the financial exigencies of the Exchequer.

If justice says that people are due compensation, and if we all say that this is our democratic will, then that is what should happen. If that puts a strain on the Exchequer and the rest of us, it is a strain that we have to bear, because we owe it to those who have suffered as they should not have suffered, and who have endured and struggled for so long, with so many people dying in the effort.

[Several hon. Members]

rose—

--- Later in debate ---

[Mr Robinson]

No motion of the House is ever wholly correct. I have never voted for a motion with which I totally agree—[Interruption.] I hate to say it, but we are reverting to party politics on an issue that has nothing to do with it. No motion is ever perfect. As the hon. Gentleman knows, we are debating a principle. We should recognise that there should be much more compensation—[Interruption.] If Conservative Members think that this is a laughing matter, I will leave it to them and their consciences.

[Mark Durkan]

Did my hon. Friend note that the Minister said that as well as placing in the Library an explanation of how the figures were arrived at, she would place a copy of an article from The Irish Times, quoting Brian Cowen, who was then Minister of Health in the Republic? Brian Cowen became Minister of Health in 1997, but the compensation scheme in the south began in 1996 and issued significant payments then. There are misleading versions of what subsequent tribunals said and what was admitted by the Irish Government, but the Irish compensation scheme was not based on that admission of liability or that knowledge.

[Mr Robinson]

I am very grateful to my hon. Friend for that intervention. Perhaps the Minister would like to say whether that is correct. Perhaps she does not know. The debate is degenerating into the to and fro of Opposition against Government interchanges. Let me assure the Health Secretary and the Minister that no one who has taken part in the debate really wants that.

The simple fact of why we are proposing this motion and resisting the Government amendment is that we are pressing for a recognition that a gross injustice has taken place and that it must be put right. That will involve high levels of compensation. We beg the Government not to believe the figures that are automatically produced to exaggerate the situation.